Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline without detailed documentation

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1972
Report date:
1972

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 414 (Prenatal Developmental Toxicity Study)
Deviations:
yes
Remarks:
(documentation deficiencies)
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Calcium dipropionate
EC Number:
223-795-8
EC Name:
Calcium dipropionate
Cas Number:
4075-81-4
Molecular formula:
C3H6O2.1/2Ca
IUPAC Name:
calcium dipropanoate
Details on test material:

- Name of test material (as cited in study report): calcium propionate
- Physical state: fine white crystalline
- Analytical purity: no data

Test animals

Species:
rat
Strain:
Wistar
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: no data
- Age at study initiation: adult
- Average body weight at study initiation: 229.5 g
- Fasting period before study: no data
- Housing: individually
- Diet (e.g. ad libitum): free access
- Water (e.g. ad libitum): tap water, free access
- Acclimation period: no data

ENVIRONMENTAL CONDITIONS
- Animals were housed in temperature and humidity controlled quarters

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
not specified
Details on exposure:
PREPARATION OF DOSING SOLUTIONS: no data

Analytical verification of doses or concentrations:
not specified
Details on mating procedure:
- Impregnation procedure: cohoused
- If cohoused:
- M/F ratio per cage: no data
- Length of cohabitation: no data
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as day 0
- Any other deviations from standard protocol: no
Duration of treatment / exposure:
days 6-15 of gestation
Frequency of treatment:
daily
Duration of test:
20 days
Doses / concentrations
Remarks:
Doses / Concentrations:
3, 14, 65, 300 mg/kg bw
Basis:
actual ingested
No. of animals per sex per dose:
24 females
Control animals:
yes, sham-exposed
Details on study design:
- Dose selection rationale: no data
- Rationale for animal assignment (if not random): no data
- Positive control: Acetylsalicyl acid (ASA) administered at 250 mg/kg bw

Examinations

Maternal examinations:
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily

BODY WEIGHT: Yes
- Time schedule for examinations: Days 0, 6, 11, 15 and 17 of gestation


FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes
- Frequency of measurement: daily


POST-MORTEM EXAMINATIONS: Yes
- Sacrifice: on gestation day 20 by surgical anaesthesia
- Organs examined: no data


Ovaries and uterine content:
The ovaries and uterine content was examined after termination: Yes, the number of live and dead foetuses were recorded
Examinations included:
- Gravid uterus weight: No
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of resorptions: Yes
Fetal examinations:
- External examinations: Yes: [all per litter]
- Soft tissue examinations: Yes: [one third per litter]
- Skeletal examinations: Yes: [two thirds per litter]
- Head examinations: no

Results and discussion

Results: maternal animals

Maternal developmental toxicity

Details on maternal toxic effects:
Maternal toxic effects:no effects

Details on maternal toxic effects:
The administration of up to 300 mg/kg (body weight) of the test material to pregnant rats for 10 consecutive days had no clearly discernible effect on on dams.

Effect levels (maternal animals)

Dose descriptor:
NOAEL
Effect level:
300 mg/kg bw/day (actual dose received)
Basis for effect level:
other: maternal toxicity

Results (fetuses)

Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects:no effects

Details on embryotoxic / teratogenic effects:
TEST SUBSTANCE:
- The administration of up to 300 mg/kg (body weight) of the test material to pregnant rat for 10 consecutive days had no clearly discernible effect on nidation or fetal survival.
- The number of abnormalities seen in either soft or skeletal tissues of the test groups did not differ from the number occurring spontaneously in the sham-treated controls


POSITIVE CONTROL (ASA)
- Weight reduction in foetuses of dams treated with 250 mg/kg bw with a reduction of the average weight of about 41.4 compared to controls
- Increased number of total resorptions with a total number of resorptions in the positive control reaching 102 as compared to only 6 in the controls. There was also an increased percentage of partial and complete resorption in comparison to negative control animals. The percentage of partial resorptions in positive control animals was 79.2% compared to only 17.4 in negative control animals. Twenty five percent of the embryos were completed resorbed as compared to 0% in the negative control animals.
- An average of 6.6 fetuses/ dam were alive at necropsy in the positive control group totalling 160 in all. In comparison, 10.6 fetuses/ dam were alive in the negative control group making a total of 243 fetuses
- Skeletal investigations revealed malformations and variations of the sternebrae, ribs, verterbrae, skull and extremities in animals of the positive control group (see attachment). Miscellaneous findings included missing and reduced hyoids
- Soft tissue investigations included exencephaly, spina bifida, enterohepatocele

Effect levels (fetuses)

Dose descriptor:
NOAEL
Effect level:
300 mg/kg bw/day (actual dose received)
Basis for effect level:
other: teratogenicity

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Any other information on results incl. tables

see attachment for summary of results

Applicant's summary and conclusion